Harvard Medical School / Brigham and Women's Hospital

Vikram Khurana, MD PhD, is Chief of the Division of Movement Disorders at Brigham and Women’s Hospital and Harvard Medical School. He has advanced our understanding of alpha-synucleiopathy, the fundamental pathology associated with Parkinson’s disease (PD). Khurana helped pioneer human stem-cell technologies for the understanding of PD and has helped advance drugs to clinical trials. His central goal is to develop precision medicines for PD and related disorders. He is a former Fulbright Scholar, New York Stem Cell Foundation Robertson Stem Cell Investigator, Aligning Science Across Parkinson’s (ASAP) Investigator and APDA Cotzias fellow. He founded two neurodegeneration-focused biotech companies.